Max Robotics — Global Service Robot Directory + US Certification

About

Hiroki Kawabata’s research focuses on improving surgical outcomes and quality of life for prostate and kidney cancer patients, with a particular emphasis on robotic-assisted procedures. His major contributions include identifying myosteatosis (fatty muscle degeneration) as a novel predictor of post-prostatectomy urinary incontinence—a finding that helps surgeons better counsel patients on recovery risks. He also conducted the first prospective study on the natural history of asymptomatic pseudoaneurysms after robot-assisted partial nephrectomy, providing critical data that can guide postoperative surveillance without unnecessary interventions. Kawabata’s comparative analysis of robot-assisted radical prostatectomy versus high-dose-rate brachytherapy combined with radiation and hormone therapy for high-risk prostate cancer offers valuable insights into both oncological outcomes and health-related quality of life—a key consideration for treatment decision-making. With over 37 citations across his most cited works, his research is gaining traction in urologic oncology. His work directly addresses the real-world challenges patients face after surgery, from incontinence to vascular complications, making his findings immediately relevant to clinical practice.